Friday, August 19, 2011

Chemical genetics identify eIF2a kinase heme-regulated inhibitor as an anticancer target.

This is a great article that demonstrates the use of some specific N,N'-diarylureas to activate the heme-regulated inhibitor kinase leading to a decreasing occurrence of elF2-GTP-tRNAiMet translation initiation complex. These results could bring better understanding and potential treatments for diseases such as cancer and certain anemias.

2 comments:

  1. The dual luciferase activity assay in this paper is interesting. As abundance of the ternary complex decreases, more F-luc is translated since it is attached to the ATF-4 5'UTR. Since R-luc is not attached to ATF-4 5'UTR, its translation decreases (as with most genes) when less ternary complex is present. The ratio of these two luciferases gives a good measure of how much ternary complex is present under a given set of circumstances. The authors of the paper used this capability to find some potential drugs for cancer treatment.

    ReplyDelete
  2. I am just about to post this paper and I find it's already here. Chemical genetics is new to me. Yesterday I was wondering what the word 'genetics' means, then I found the definition from Internet:'Chemical genetics uses small molecules to change the way proteins work—directly in real time rather than indirectly by manipulating their genes.'

    In this paper I find out that small molecules can interact not only with proteins, but also protein complexes. I am not sure I fully understand the dual luciferase activity assay, hopefully I can learn more from the upcoming Tuesday class.

    ReplyDelete